Middle Eastern Penny Stocks To Watch In May 2025
The Middle Eastern stock markets have recently experienced a boost, with most Gulf shares gaining following the US-China tariff deal and positive economic developments in the region. Investing in penny stocks, while an older term, remains relevant as these stocks often represent smaller or newer companies that can offer significant growth opportunities at lower price points. When these companies boast strong financial health and solid fundamentals, they may provide investors with attractive upside potential without many of the typical risks associated with this market segment.
Name
Share Price
Market Cap
Financial Health Rating
Thob Al Aseel (SASE:4012)
SAR4.20
SAR1.68B
★★★★★★
Keir International (SASE:9542)
SAR3.92
SAR474M
★★★★★☆
Alarum Technologies (TASE:ALAR)
₪2.597
₪181.87M
★★★★★★
Oil Refineries (TASE:ORL)
₪0.898
₪2.79B
★★★★★☆
Tarya Israel (TASE:TRA)
₪0.565
₪167.73M
★★★★★☆
Tgi Infrastructures (TASE:TGI)
₪2.222
₪165.19M
★★★★★★
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.69
AED419.7M
★★★★★★
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.38
AED390.39M
★★★★★★
E7 Group PJSC (ADX:E7)
AED1.03
AED2.06B
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.36
AED10.08B
★★★★☆☆
Click here to see the full list of 93 stocks from our Middle Eastern Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Tukas Gida Sanayi ve Ticaret A.S. manufactures and sells food products both in Turkey and internationally, with a market cap of TRY11.97 billion.
Operations: Tukas Gida Sanayi ve Ticaret A.S. does not report specific revenue segments.
Market Cap: TRY11.97B
Tukas Gida Sanayi ve Ticaret A.S. has demonstrated significant earnings growth over the past five years, with a notable annual increase of 38.8%. Despite a recent slowdown to 5.1% growth last year, it still outpaced the broader food industry decline. The company is debt-free, enhancing its financial stability and reducing interest payment concerns. Tukas's net profit margins have improved slightly from last year, and its price-to-earnings ratio suggests good value compared to the Turkish market average. Recent earnings reports show a return to profitability with TRY488.15 million in net income for Q1 2025 after a loss in the previous year's quarter.
Click here to discover the nuances of Tukas Gida Sanayi ve Ticaret with our detailed analytical financial health report.
Understand Tukas Gida Sanayi ve Ticaret's track record by examining our performance history report.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Alinma Retail REIT Fund is a real estate investment fund with a market cap of SAR 547.52 million.
Operations: The fund's revenue is primarily derived from real estate rental, totaling SAR 187.74 million.
Market Cap: SAR547.52M
Alinma Retail REIT Fund, with a market cap of SAR 547.52 million, has shown financial improvement by becoming profitable in the last year. Its revenue from real estate rental reached SAR 187.74 million, marking a significant increase from the previous year. The fund's debt management appears solid, with interest payments well-covered by EBIT and operating cash flow effectively covering debt levels. However, short-term assets do not cover long-term liabilities fully. Recent dividend distributions indicate an unstable track record but provide some return to investors at SAR 0.32 per unit for the year ending December 2024.
Dive into the specifics of Alinma Retail REIT Fund here with our thorough balance sheet health report.
Evaluate Alinma Retail REIT Fund's historical performance by accessing our past performance report.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Oil Refineries Ltd., with a market cap of ₪2.79 billion, primarily produces and sells fuel products, intermediate materials, and aromatic products both in Israel and internationally.
Operations: The company's revenue is primarily derived from its Refining segment, which generated $6.73 billion, followed by the Polymers segment with $806 million.
Market Cap: ₪2.79B
Oil Refineries Ltd., with a market cap of ₪2.79 billion, has seen its earnings decline significantly over the past year, with net income dropping to US$113 million from US$408 million. Despite this, the company maintains strong liquidity, as short-term assets exceed both short-term and long-term liabilities. The company's debt management shows improvement, with a satisfactory net debt to equity ratio of 22.2% and operating cash flow effectively covering debt obligations. However, profit margins have decreased to 1.5%, and interest payments are not well covered by EBIT at 2.4 times coverage, indicating potential financial strain despite high-quality earnings and experienced leadership.
Navigate through the intricacies of Oil Refineries with our comprehensive balance sheet health report here.
Assess Oil Refineries' previous results with our detailed historical performance reports.
Explore the 93 names from our Middle Eastern Penny Stocks screener here.
Interested In Other Possibilities? AI is about to change healthcare. These 23 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:TUKAS SASE:4345 and TASE:ORL.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
22 minutes ago
- Fox News
Business Rundown: High State Trade Talks Between U.S., China Began
Kicking off what will no doubt be a big week in economic news, the White House's top trade officials are meeting with their Chinese counterparts in London. Their goal is to end the ongoing trade war and reach a deal that will provide a much-needed boost to America's manufacturers. While we're coming off a better-than-expected May jobs report, the stakes remain high for Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick, and Trade Representative Jamieson Greer, as Wall Street and Main Street have been somewhat anxious about President Trump's tariff strategy. Also, on the minds of investors, this week's inflation report, the fallout from the President's fallout with Elon Musk, and the fate of that one big beautiful bill. Lou Basenese, the Executive Vice President of Market Strategy at Prairie Operating, joins FOX Business Network's Lydia Hu to discuss the importance of the U.S.-China trade talks, Wednesday's inflation data, and the other big stories that could move the market this week. Learn more about your ad choices. Visit
Yahoo
24 minutes ago
- Yahoo
AMD price target lift, Apple's WWDC, Chewy downgrade
Market Domination co-host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. Advanced Micro Devices (AMD) stock gains after Citi lifts its price target to $120 from $100, citing upcoming artificial intelligence (AI) catalysts and advantages over Nvidia (NVDA). Apple (AAPL) is kicking off its Worldwide Developers Conference on Monday, where the company is expected to unveil key software updates. Chewy (CHWY) stock slides after Mizuho downgraded the stock to Neutral from Outperform. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo Finance's market minute. US stocks seesaw as investors eye renewed US-China trade talks. Wall Street looking for signs of either side willing to dial down tensions and reach a tariff deal. AMD shares getting a lift as City raises its price target on that stock from 100 to 120. City highlighting potential positive catalyst, the second half of the year and sees the chip maker as having some advantages over Nvidia. The price target change comes ahead of AMD's advancing AI event, which is taking place on June 12th. Apple kicking off its worldwide developers conference on Monday. The iPhone maker offering a look at the changes coming to the company's software products throughout the next year. Apple expected to reveal software and design updates. And Chewy shares, they're sliding as Mizuho hits the stock with a downgrade, lowering its rating from outperform to neutral. Mizuho citing the pet food company's unattractive positioning, noting quote, several potential landmines for the first quarter. And that's your Yahoo Finance market minute. Sign in to access your portfolio
Yahoo
43 minutes ago
- Yahoo
June 2025's Spotlight On Promising Penny Stocks
As the U.S. stock market experiences a rally fueled by optimism over U.S.-China trade talks and robust corporate earnings, investors are increasingly exploring diverse investment opportunities. Penny stocks, a term that may seem outdated yet remains relevant, represent shares of smaller or newer companies that can offer significant growth potential when backed by strong financial health. In this article, we will explore several penny stocks that demonstrate balance sheet strength and long-term potential, providing investors with opportunities to uncover hidden value in the market. Name Share Price Market Cap Financial Health Rating Imperial Petroleum (IMPP) $3.02 $103.93M ★★★★★★ New Horizon Aircraft (HOVR) $0.935 $29.35M ★★★★★★ Waterdrop (WDH) $1.475 $533.45M ★★★★★★ Greenland Technologies Holding (GTEC) $2.06 $35.83M ★★★★★★ WM Technology (MAPS) $1.11 $186.68M ★★★★★★ Perfect (PERF) $1.815 $184.86M ★★★★★★ Table Trac (TBTC) $4.86 $22.55M ★★★★★★ Flexible Solutions International (FSI) $4.32 $54.64M ★★★★★★ BAB (BABB) $0.8311 $6.04M ★★★★★★ Lifetime Brands (LCUT) $3.43 $76.88M ★★★★★☆ Click here to see the full list of 709 stocks from our US Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated and metabolic diseases, with a market cap of approximately $159.32 million. Operations: Aldeyra Therapeutics, Inc. does not report any revenue segments. Market Cap: $159.32M Aldeyra Therapeutics, with a market cap of US$159.32 million, is a pre-revenue biotechnology firm navigating the challenging landscape of clinical trials and regulatory approvals. Despite recent setbacks from the FDA regarding its dry eye treatment candidate reproxalap, the company achieved significant milestones in Phase 3 trials that may address previous concerns. Financially, Aldeyra maintains strong short-term liquidity with US$92.7 million in assets against liabilities and has more cash than debt, providing a runway exceeding one year. However, high volatility and ongoing losses highlight inherent risks typical for companies at this developmental stage in the biotech sector. Unlock comprehensive insights into our analysis of Aldeyra Therapeutics stock in this financial health report. Explore Aldeyra Therapeutics' analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Maravai LifeSciences Holdings, Inc. is a life sciences company that offers products supporting the development of drug therapies, vaccines, cell and gene therapies, and diagnostics across various global regions with a market cap of $608.64 million. Operations: The company generates revenue primarily from Nucleic Acid Production, which accounts for $179.08 million, and Biologics Safety Testing, contributing $62.78 million. Market Cap: $608.64M Maravai LifeSciences Holdings, with a market cap of US$608.64 million, faces challenges typical for penny stocks, including recent declines in sales and increased net losses. The company reported first-quarter sales of US$46.85 million, down from US$64.18 million a year prior, and a net loss of US$29.95 million compared to the previous year's US$12.08 million loss. Despite its unprofitability, Maravai has strong short-term liquidity with assets surpassing both short- and long-term liabilities and has reduced its debt-to-equity ratio over five years from 262.7% to 55.6%, indicating improved financial management amidst volatility concerns. Navigate through the intricacies of Maravai LifeSciences Holdings with our comprehensive balance sheet health report here. Assess Maravai LifeSciences Holdings' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ranpak Holdings Corp. offers product protection and end-of-line automation solutions for e-commerce and industrial supply chains across North America, Europe, and Asia, with a market cap of approximately $306.61 million. Operations: The company generates $374.8 million in revenue from its product protection and automation solutions for e-commerce and industrial supply chains. Market Cap: $306.61M Ranpak Holdings, with a market cap of US$306.61 million, exemplifies the volatility and potential of penny stocks. Despite being unprofitable with increasing losses over five years and a negative return on equity, Ranpak maintains a seasoned management team and board. The company reported first-quarter revenue growth to US$91.2 million but also faced a net loss of US$10.9 million. Recent strategic partnerships, like the one with Thalia for automated packaging systems, highlight its commitment to innovation in e-commerce fulfillment solutions while managing high debt levels and maintaining sufficient cash runway for over three years. Click to explore a detailed breakdown of our findings in Ranpak Holdings' financial health report. Understand Ranpak Holdings' earnings outlook by examining our growth report. Explore the 709 names from our US Penny Stocks screener here. Ready To Venture Into Other Investment Styles? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ALDX MRVI and PACK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data